Keywords: amgen, anakinra, cuts, joint, destruction, ra, interleukin-1

Amgen's anakinra cuts joint destruction in RA

Article | 22 June 2001

Amgen's interleukin-1 receptor antagonist anakinra has been shown toarrest joint destruction and improve function in a 472-patient study in rheumatoid ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Amgen

Go to company listing

Related Drugs

Anakinra

Kineret

Go to drug listing